– An Invitae-developed innovative approach to help reduce variants of uncertain significance – SAN FRANCISCO, March 12, 2024 /PRNewswire/ — Invitae (OTC: NVTA), a leading medical genetics company, today announced the launch of an update to Invitae Generation™ with Clinical Variant…